Ashok Kuruganti joins EyeCare4Kids board

Article

Mr. Kuruganti’s role on the board will include outreach to many in the software and tech industries, as well as offering expert advice to the organization as EyeCare4Kids expands services both on a domestic and international level.


Salt Lake City, UT – EyeCare4Kids, the nation’s largest nonprofit provider of vision screenings, eye exams, and eyeglasses for underprivileged children, today announced that Mr. Ashok Kuruganti has accepted a board position within the organization.

Ashok started his career in enterprise Software at Oracle in 1991 and rose to executive ranks very quickly holding SVP and CRO at some of the world’s most notable Hypergrowth Enterprise software technologies companies. He currently works at Pluralsight as a Senior Strategic Account Executive and will join the board immediately.

Mr. Kuruganti’s role on the board will include outreach to many in the software and tech industries, as well as offering expert advice to the organization as EyeCare4Kids expands services both on a domestic and international level.

“We are absolutely thrilled to have Ashok join our board of directors,” says Joseph Carbone, EyeCare4Kids Founder, President and CEO. “We have admired his career achievements from a distance and his dedication to being the best in every aspect of his life. We understand the role technology plays in our ambitious development and expansion plans, and we will value Ashok’s input as we grow to provide eye care services to children and families around the globe.”

Mr. Kuruganti is committed to “doing good,” and has spent multiple years helping the American Diabetes Association’s Tour de Cure in the Seattle area. In a peculiar and fun twist, it’s valuable to note that back in the day, Ashok toured as a guest guitarist with Steppenwolf.

“Proper and professional eye care opens a world of possibilities to any child, anywhere,” says Mr. Kuruganti. “The world is becoming more technology-based every day and each child deserves the right to professional screenings, eye care, and eyeglasses as they discover how to change the world in their own way. I am happy and excited to offer my expertise and life experience to help these children realize their overall potential.”

Recent Videos
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
© 2024 MJH Life Sciences

All rights reserved.